SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ONXX
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (776)2/6/2004 3:10:55 AM
From: tuck  Read Replies (1) of 810
 
ONXX has a had a nice recovery since announcing their restructuring to focus on BAY 43-9006. In order to keep the thread alive and easily searchable I dredge it up again for posterity. As part of the restructuring, ONXX dropped all gene therapy and therapeutic virus development. Said it would try to outlicense them, and nobody has bitten. But perhaps all hope is not lost. A couple of authors with no financial conflicts have recently posited that there is yet some use for ONYX-015:

jco.org

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News